Republican Gov. Ron DeSantis’ office has vowed to appeal.
Health
New device, medication help Maine paramedics improve baby delivery
Former EMS protocol required paramedics to transport mothers and babies in separate ambulances. Now crews can carry them together, giving a mother and her child more time to connect.
Alzheimer’s drug that can slow disease gets backing from FDA advisers
If it wins final approval, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. that’s been shown to convincingly slow cognitive decline and memory problems due to Alzheimer’s.
At Safe Harbor in Machias, a place for women in recovery – and their kids
The Down East certified recovery home is one of just two in Maine that allows women to bring their children.
Businesses air concerns about proposed rules of new paid family leave program
Some companies that plan to offer their own programs object to paying into the state program during its 16-month startup period. The 1% payroll tax is split evenly between employers and their workers.
Senate Republicans vote against making contraception a federal right
Sens. Susan Collins and Lisa Murkowski, R-Alaska, who support abortion rights, were the sole Republicans who voted to proceed on the bill.
Maine woman files class-action lawsuit against Cigna for denying coverage of weight-loss medication
Jamie Whittemore’s suit, which her attorneys believe is the first of its kind in the nation, says drugs to treat obesity must be covered because the Affordable Care Act prohibits discrimination based on a disability.
‘Maine has lost sight of parents’ and children’s right to be together’: The case of Barni A.
A state supreme court case found a mother’s parental rights were unfairly terminated, providing a rare glimpse inside the opaque child welfare system.
Maine’s health department rarely investigates when residents wander away from care facilities
Elopement – when a resident wanders out of a care home – is a real risk, particularly for people with dementia. But in the vast majority of cases, the facilities are never inspected and rarely sanctioned.
Ozempic cuts risk of death from kidney disease, major study finds
Novo Nordisk, the maker of Ozempic will seek FDA approval to dramatically expand the number of patients eligible for the shots.